Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2005, p. 3338-3347, Vol. 25, No. 8
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.8.3338-3347.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Xianghong Zou,1
Asish K. Ghosh,3,
John Varga,3,
Giulio F. Draetta,2 and
Hiroaki Kiyokawa1*
Department of Biochemistry and Molecular Genetics,1 Section of Rheumatology, University of Illinois College of Medicine, Chicago, Illinois,3 European Institute of Oncology, Milan, Italy2
Received 26 August 2004/ Returned for modification 21 September 2004/ Accepted 3 January 2005
Ubiquitin-dependent degradation of Cdc25A is a major mechanism for damage-induced S-phase checkpoint. Two ubiquitin ligases, the Skp1-cullin-ß-TrCP (SCFß-TrCP) complex and the anaphase-promoting complex (APCCdh1), are involved in Cdc25A degradation. Here we demonstrate that the transforming growth factor ß (TGF-ß)-Smad3 pathway promotes SCFß-TrCP-mediated Cdc25A ubiquitination. Cells treated with TGF-ß, as well as cells transfected with Smad3 or a constitutively active type I TGF-ß receptor, exhibit increased ubiquitination and markedly shortened half-lives of Cdc25A. Furthermore, Cdc25A is stabilized in cells transfected with Smad3 small interfering RNA (siRNA) and cells from Smad3-null mice. TGF-ß-induced ubiquitination is associated with Cdc25A phosphorylation at the ß-TrCP docking site (DS82G motif) and physical association of Cdc25A with Smad3 and ß-TrCP. Cdc25A mutant proteins deficient in DS82G phosphorylation are resistant to TGF-ß-Smad3-induced degradation, whereas a Cdc25A mutant protein defective in APCCdh1 recognition undergoes efficient degradation. Smad3 siRNA inhibits ß-TrCP-Cdc25A interaction and Cdc25A degradation in response to TGF-ß. ß-TrCP2 siRNA also inhibits Smad3-induced Cdc25A degradation. In contrast, Cdh1 siRNA had no effect on Cdc25A down-regulation by Smad3. These data suggest that Smad3 plays a key role in the regulation of Cdc25A ubiquitination by SCFß-TrCP and that Cdc25A stabilization observed in various cancers could be associated with defects in the TGF-ß-Smad3 pathway.
Present address: Department of Obstetrics and Gynecology, Osaka University Medical School, Osaka 565-0871, Japan.
Present address: Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|